Proceedings from a live event on May 29, 2026, held adjunct to the 2026 ASCO Annual Meeting and moderated by Dr Jeremy S Abramson. Published July 2026.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
AMA PRA Category 1 Credit™Up to 2.25 credits
MOC types
ABIM — Medical KnowledgeUp to 2.25 points
FDA REMS
No
Qualifies for MIPS
No
Target Specialties
Pricing
100% of listed courses are free
240 of 240 courses listed here are free.
Collected from the provider’s public pages
Specialties served/covered
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Enduring / On-demand
- Credit · Up to 2.25 credits
- MOC · Up to 2.25 points
-
ReleasedAug 5, 2026
-
Last day to claim creditAug 7, 2027 10 months left
-
American Society of Clinical Oncology Selecting Optimal Therapies for Chronic Lymphocytic Leukemia Across the Disease Spectrum: Worldwide Perspectives – 2026 ASCO Annual Meeting
-
Physicians’ Education Resource Module 3: Chronic Lymphocytic Leukemia (CLL)
-
CLL Society +1 CLL Challenge! Interrogating the Latest Evidence on Patient Priorities and Novel Targeted Therapies
-
Research to Practice The Implications of Recent Datasets for the Current and Future Management of Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia An ASCO/EHA 2026 Review | 2026 (Webinar Proceedings)
-
Research to Practice Cases from the Community: Investigators Discuss the Optimal Management of EGFR-Mutated Non-Small Cell Lung Cancer | 2026 (Symposium Proceedings)
-
Research to Practice Consensus or Controversy? Documenting and Discussing Investigators Approaches to the Management of Relapsed/Refractory Multiple Myeloma | 2026 (Symposium Proceedings)
